| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Curis Inc (CRIS) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 23 sells. CRIS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $202.0K | - | |
| CFO | 135.0K | $75.7K | - | |
| Other | 135.0K | $75.7K | - | |
| Dir | 14.4K | $8.1K | - | |
| Dir | 14.4K | $8.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2017 | Fattaey Ali Ph.d. | President &CEO | Buy | 50,000 | $1.06 | $53,000.00 | +75.9% | |
| May 5, 2017 | McNab James R | Director | Sell | 76,276 | $2.04 | $155,424.00 | -26.4% | |
| May 2, 2017 | McNab James R | Director | Sell | 116,708 | $2.38 | $278,037.28 | -19.3% | |
| Apr 27, 2017 | McNab James R | Director | Sell | 146,694 | $2.61 | $383,019.32 | -6.0% | |
| Apr 24, 2017 | McNab James R | Director | Sell | 110,322 | $2.59 | $285,682.37 | -2.7% | |
| May 27, 2016 | Greenacre Martyn D | Director | Sale+OE | 15,000 | $1.69 | $25,350.00 | -17.6% | |
| May 26, 2016 | Kaitin Kenneth I | Director | Sale+OE | 15,000 | $1.76 | $26,400.00 | -21.9% | |
| Dec 30, 2015 | Passeri Daniel R | Director | Sale+OE | 25,600 | $2.97 | $75,936.00 | -6.0% | |
| Dec 28, 2015 | Passeri Daniel R | Director | Sale+OE | 13,600 | $2.85 | $38,780.00 | -3.3% | |
| Dec 23, 2015 | Passeri Daniel R | Director | Sale+OE | 48,900 | $2.78 | $136,110.00 | -10.9% |